Pathogenicity determinants of Candida albicans: potential targets for immunotherapy?
Matthews
R C
RC
Department of Medical Microbiology, University of Manchester Medical School, UK.
D000908:Antibodies, Fungal / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use*; D002176:Candida albicans / Q000235:genetics / Q000472:pathogenicity*; D002177:Candidiasis / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007167:Immunotherapy; D014774:Virulence
D000908:Antibodies, Fungal; D000935:Antifungal Agents